SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16,619.76 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 5,296.00 |
| Book Value / Share | 85.02 |
| Price / Book | n/a |
| NCAV ($M) | 2,747.00 |
| NCAV / Share | 44.10 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 1.44 |
| Return on Assets (ROA) | 0.21 |
| Return on Equity (ROE) | 0.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.32 |
| Current Ratio | 5.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4,037.00 |
| Assets | 6,586.00 |
| Liabilities | 1,290.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 21,526.00 |
| Operating Income | 7,079.00 |
| Net Income | 7,844.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 7,771.00 |
| Cash from Investing | -9,907.00 |
| Cash from Financing | -3,919.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
Financial data and stock pages provided by
Fintel.io